AstraZenica Resumes UK Arm of COVID Vaccine Trial

After pausing their phase 2/3 study for a COVID-19 vaccine, AstraZenica has resumed the trial in the United Kingdom. According to news reports, the Medicines Health Regulatory Authority in the UK, which overseas clinical trials, recommended the continuation. The trial had been temporarily stopped on September 6 when one volunteer who had received the vaccine became ill.

The pause was to allow researchers to learn if the illness was related to the vaccine or a coincidence. There is no word yet…

Read Entire Article Here…

Leave a Reply

Your email address will not be published. Required fields are marked *